PCM
PTLA
Prelude Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-259,762
| Closed | -$4.67M | – | 2090 |
|
|
2020
Q2 | $4.67M | Buy |
+259,762
| New | +$4.67M | 0.26% | 16 |
|
|
2019
Q3 | – | Sell |
-34,328
| Closed | -$931K | – | 1778 |
|
|
2019
Q2 | $931K | Buy |
34,328
+10,978
| +47% | +$298K | 0.05% | 188 |
|
|
2019
Q1 | $810K | Buy |
+23,350
| New | +$810K | 0.05% | 196 |
|
|
2018
Q4 | – | Sell |
-113,350
| Closed | -$3.02M | – | 1895 |
|
|
2018
Q3 | $3.02M | Buy |
113,350
+68,978
| +155% | +$1.84M | 0.18% | 68 |
|
|
2018
Q2 | $1.68M | Buy |
+44,372
| New | +$1.68M | 0.11% | 157 |
|
|
2018
Q1 | – | Sell |
-187
| Closed | -$9K | – | 1666 |
|
|
2017
Q4 | $9K | Sell |
187
-3
| -2% | -$144 | ﹤0.01% | 1086 |
|
|
2017
Q3 | $10K | Sell |
190
-57
| -23% | -$3K | ﹤0.01% | 1309 |
|
|
2017
Q2 | $14K | Sell |
247
-853
| -78% | -$48.3K | ﹤0.01% | 1225 |
|
|
2017
Q1 | $43K | Buy |
+1,100
| New | +$43K | ﹤0.01% | 1012 |
|
|
2015
Q1 | – | Sell |
-4,400
| Closed | -$125K | – | 2186 |
|
|
2014
Q4 | $125K | Buy |
+4,400
| New | +$125K | 0.02% | 860 |
|